Skip to search
Skip to main content
Back to Search
Start Over
An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A (vol 9, 199, 2014)
Authors :
Attarian, S Vallat, J-M Magy, L Funalot, B Gonnaud, P-M Lacour, A Pereon, Y Dubourg, O Pouget, J Micallef, J Franques, J Lefebvre, M-N Ghorab, K Al-Moussawi, M Tiffreau, V Preudhomme, M Magot, A Leclair-Visonneau, L Stojkovic, T Bossi, L Lehert, P Gilbert, W Bertrand, V Mandel, J Milet, A Hajj, R Boudiaf, L Scart-Gres, C Nabirotchkin, S Guedj, M Chumakov, I Cohen, D Attarian, S Vallat, J-M Magy, L Funalot, B Gonnaud, P-M Lacour, A Pereon, Y Dubourg, O Pouget, J Micallef, J Franques, J Lefebvre, M-N Ghorab, K Al-Moussawi, M Tiffreau, V Preudhomme, M Magot, A Leclair-Visonneau, L Stojkovic, T Bossi, L Lehert, P Gilbert, W Bertrand, V Mandel, J Milet, A Hajj, R Boudiaf, L Scart-Gres, C Nabirotchkin, S Guedj, M Chumakov, I Cohen, D
Publication Year :
2016
Details
Database :
OAIster
Publication Type :
Electronic Resource
Accession number :
edsoai.on1340015659
Document Type :
Electronic Resource